Key Metrics
Journal Specifications
- PublisherFUTURE MEDICINE LTD
- LanguageEnglish
- FrequencySemi-monthly
- LanguageEnglish
- FrequencySemi-monthly
- Publication Start Year2009
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 10% |
4-6 | 61% |
7-9 | 21% |
>9 | 7% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Epigenomics been publishing? 
The Epigenomics has been publishing since 2009 till date.
How frequently is the Epigenomics published? 
Epigenomics is published Semi-monthly.
Who is the publisher of Epigenomics? 
The publisher of Epigenomics is FUTURE MEDICINE LTD.
How can I view the journal metrics of Epigenomics on editage? 
For the Epigenomics metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Epigenomics? 
The eISSN number is 1750-192X and pISSN number is 1750-1911 for Epigenomics.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Transcription factor, Cancer, DNA methylation, Intermittent fasting, Chromatin, Histone deacetylase inhibitor, Psychosis, Heart disease, RNA editing, Cord blood, Nitric oxide, Maternal anxiety, Depressive symptoms, Overall survival, Lipid profile, Bioinformatics analysis, Mirna expression, Melatonin, Colorectal cancer, Differential Methylation.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.